Page 8 - Applied Dna Sciences News Today

06.09.2022 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”), a leader in PCR-based DNA technologies, announced today that its wholly-owned clinical laboratory subsidiary, Applied DNA Clinical Labs, LLC (“ADCL”), has launched monkeypox ... Seite 1

- Post-Quarter Close Cash Balance of $16.8 Million Includes Proceeds from Upsized Public Offering and Warrant Exercises - - Company to Hold Conference Call and Webcast Today,... | August 11, 2022

10.08.2022 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in PCR-based DNA technologies, today announced that LineaRx, the Company’s majority-owned biotherapeutics subsidiary, has for the first time successfully administered and expressed ... Seite 1

08.08.2022 - Applied DNA Sciences, Inc., (NASDAQ: APDN) (the “Company” or “Applied DNA”), a leader in polymerase chain reaction (PCR)-based technologies, today announced the closing of its previously announced public offering of 3,000,000 shares of its common ... Seite 1

Applied DNA Sciences (NASDAQ:APDN – Get Rating) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a note issued to investors on Monday, Zacks.com reports. According to Zacks, “Applied DNA Sciences, Inc. provides proprietary DNA-embedded biotechnology security solutions, using non-human DNA, that verify authenticity and protect corporate and government […]

Applied DNA Sciences (NASDAQ:APDN – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued on Thursday, Zacks.com reports. The firm presently has a $1.50 price target on the technology company’s stock. Zacks Investment Research‘s price target suggests a potential upside of 9.49% from […]

Brokerages predict that Applied DNA Sciences, Inc. (NASDAQ:APDN – Get Rating) will post $4.65 million in sales for the current quarter, according to Zacks. Two analysts have provided estimates for Applied DNA Sciences’ earnings. The lowest sales estimate is $4.45 million and the highest is $4.85 million. Applied DNA Sciences reported sales of $2.67 million […]

Wall Street analysts expect Applied DNA Sciences, Inc. (NASDAQ:APDN – Get Rating) to announce $4.65 million in sales for the current quarter, according to Zacks Investment Research. Two analysts have provided estimates for Applied DNA Sciences’ earnings, with estimates ranging from $4.45 million to $4.85 million. Applied DNA Sciences reported sales of $2.67 million during […]

Wall Street brokerages forecast that Applied DNA Sciences, Inc. (NASDAQ:APDN – Get Rating) will post $4.65 million in sales for the current quarter, Zacks Investment Research reports. Two analysts have provided estimates for Applied DNA Sciences’ earnings, with the highest sales estimate coming in at $4.85 million and the lowest estimate coming in at $4.45 […]

Applied DNA Sciences (NASDAQ:APDN – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued on Tuesday, Zacks.com reports. According to Zacks, “Applied DNA Sciences, Inc. provides proprietary DNA-embedded biotechnology security solutions, using non-human DNA, that verify authenticity and protect corporate and government agencies […]